| 영문 | acetylsalicylic acid | 한글 | 아세틸살리실산 |
|---|---|---|---|
| 설명 | 상품명이 아스피린(asprin)인 약. 대표적인 비스테로이드 항염약이다. 즉 항염증(anti-inflammatory), 진통(analgesis), 해열(anti-pyretic)의 효과가 모두 뛰어나지만 위장장애, 과다호흡, 라이증후군(Reye syndrome) 등의 부작용이 있다. |
||
| 영문 | uric acid | 한글 | 요산 |
|---|---|---|---|
| 설명 | 결정성의 산. 2, 6, 8-trioxypurine. 화학식은 C5H4N4O3로 사람과 동물의 오줌에서 얻을 수 있다. 핵의 대사산물의 하나. 물, 알콜, 에테르(ether)에는 거의 녹지 않으나 알칼리염의 용액에는 녹는다. 이것의 나트륨염 형태(sodium urate)가 결석의 대부분을 차지한다. 급성백혈병 치료 초기단계와 통풍(Gout)에서 혈중요산이 급격히 오를 수 있다. |
||
| 영문 | acid-fast bacillus | 한글 | 항산막대균, 항산균 |
|---|---|---|---|
| 설명 | 아닐린 색소에 염색되기 힘드나 일단 염색되면 강산으로 처리하여도 탈색되지 아니하는 세균을 통틀어 이르는 말. 결해균, 나병균 따위가 있다. |
||
| 영문 | acid-fast staining | 한글 | 항산염색 |
|---|---|---|---|
| 설명 | 항산성성질(좀처럼 염색이 되지 않으나 한번 염색이 되면 산성용액에 의해서 탈색이 되지 않는 성질)을 가진 균(예를 들면 결핵균 등)의 검출에 이용되는 염색방법. 방법에는 Ziehl-Neelson법과 Kinyoun법 등이 있다. |
||
| 영문 | nucleic acid | 한글 | 핵산 |
|---|---|---|---|
| 설명 | 염기, 당, 인산으로 이루어진 뉴클레오티드가 긴 사슬 모양으로 중합된 고분자 물질. 유전이나 단백질 합성을 지배하는 중요한 물질로, 생물의 증식을 비롯한 생명 활동 유지에 중요한 작용을 한다. 구성 당인 오탄당이 리보오스인 리보핵산과 디옥시리보오스인 디옥시리보 핵산으로 나뉜다. 펜토스로서 리보스나 데옥시리보스 어느 한쪽만을 포함하며 전자를 리보핵산(RNA), 후자를 데옥시리보핵산(deoxyribonucleic acid, DNA)이라 부른다. 모두 4종류의 유기염기에 의해 특징지어지며 아데닌, 구아닌 및 시토신은 양자에 공통이다. 티민은 DNA에, 우라실은 RNA에 포함된다. DNA는 주로 핵에 존재하며 형질유전에 그리고 RNA는 세포질속에서 단백질 합성에 관여한다. 섭취된 핵산은 소화관에서 구성분자로까지 가수분해되어 흡수된다. |
||
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
|---|---|
| CES-D | Center for Epidemiological Studies of Depression [scale] |
| CHAS | Center for Health Administration Studies |
| HCSD | Health Care Studies Division |
| MSU | maple sugar urine; maple syrup urine; medical studies unit; mid-stream urine; monosodium urate; myoc... |
| secretory protein | <protein> In eukaryotes, proteins synthesised on rough endoplasmic reticulum and destined for export. Nearly all proteins secreted from cells are glycosylated (in the Golgi apparatus, although there are exceptions (albumin). In prokaryotes, secreted proteins may be synthesised on ribosomes associated with the plasma membrane or exported post translation. (18 Nov 1997) |
|---|---|
| secretory rate | The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa. (12 Dec 1998) |
| secretory vesicle | <cell biology> Membrane bounded vesicle derived from the Golgi apparatus and containing material that is to be released from the cell. The contents may be densely packed, often in an inactive precursor form (zymogen). (18 Nov 1997) |
| steroid secretory rate | The rate of glandular secretion of a given steroid, usually expressed as milligrams per day; does not include any amount of the steroid that might be formed extraglandularly. (05 Mar 2000) |
| IgA, secretory | The principle ig found in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. It is composed of two to four molecules of 7s IgA and one molecule each of j chain and secretory component (sc), also called secretory piece. Molecular weight appr. 400,000. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |